See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Nov. 7, 2006

Eye Disorders/Infections Diabetes - Type 2 Diabetic Neuropathy

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Eye Disorders/Infections

People 1 year old or older may be eligible to participate in this clinical study of an investigational eye drop. People with eyes that are red, crusty, sticky, or swollen may qualify.

The research site is in Oklahoma City, Okla.

More information

Please see http://www.centerwatch.com/patient/studies/cat227.html.

-----

Diabetes - Type 2

If you have type 2 diabetes you may qualify to join this study of an investigational inhaled insulin. Participation will last about seven months and will require approximately seven office visits. Candidates 18 or older who have been diagnosed with diabetes type 2 for at least six months, are currently being treated with oral diabetes medication, and have no history of lung disease may be eligible.

The research site is in Longmont, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Diabetic Neuropathy

This is a clinical study of an investigational oral drug for hand, foot, and leg pain caused by diabetes-related nerve damage. Volunteers at least 18 who have been diagnosed with type 1 or type 2 diabetes with stable blood sugar levels for the last four weeks, have had painful diabetic peripheral neuropathy for the last six months to 10 years, and have not had a stroke or a heart attack within the last year may be eligible. Study participation lasts between 6-11 weeks and requires eight office visits.

The research sites are in Tampa and Clearwater, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat253.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News